spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

14th Annual Biomarkers Congress

Biomarkers Congress UK 2019

21-22 February 2019
Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.

Biomarkers are a fundamental part of drug development, playing a critical role in drug discovery, preclinical and clinical development, diagnostics and prognostics. Across two days and over 55 presentations, senior experts will provide a comprehensive look at the marketplace to make sure you leave with an increased knowledge of the current trends influencing biomarker research. 

2019 sees the return of our popular discovery, precision medicine and clinical streams designed to provide updates across multiple therapeutic areas, from market-dominating oncology and neuroscience through to more emerging fields such as infectious, cardiovascular and rare diseases. Benefit further from case studies on topical technology innovation in this space: imaging techniques, proteomics and immuno-assays. We are also pleased to announce an additional two streams highlighting important opportunities in the biomarker market: Biomarkers for Early Detection and Prognosis and Digital Biomarkers.

Key Speakers include:

Mark Fidock, Vice President, AstraZeneca 

Frank Kramer, Director Biomarker Strategist, Bayer 

Thomas Hach, Director Healthcare Systems, Novartis 

Devangi Mehta, Director, Development Biomarkers and Bioanalytical Sciences, Biogen 

Kay-Gunnar Stubenrauch, Head of Large Molecule Bioanalytical Sciences 1, Roche 

Joanne Hackett, Chief Commercial Officer, Genomics England

The two day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions from panels and roundtables through to two workshops on clinical biomarker assay validation and data analytics.  It brings together over 350 senior industry experts and key opinion leaders in biomarkers. For more information about the programme and registration, please contact Angela Fernandez Saez at a.fernandez@oxfordglobal.co.uk

Contact Details: 

General Enquiries: +44 (0) 1865 248455

For speaker opportunities contact j.thomson@oxfordglobal.co.uk
For sponsorship opportunities contact sponsorship@oxfordglobal.co.uk
For information on registration contact marketing@oxfordglobal.co.uk
For press & marketing enquiries contact a.saez@oxfordglobal.co.uk

phone +44 1865 248 455
email marketing@oxfordglobal.co.uk
web https://bit.ly/2zInOAb
email Manchester, UK
 
Print this page
Send to a friend
   
Banner of Bio Trinity_Events_Page on Samedan
spacer
Industry Events

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

13-14 May 2019, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019. The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.
More info >>

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach combined with therapeutic expertise, regulatory know how, and global presence delivers clinical studies with an industry recognized track record.
More info >>


News and Press Releases

International biomed specialist appoints WHP to deliver key expansion project

New state of the art cleanroom facilities will enable a leading international gene and cell therapy company to expand its bioprocessing operations and manufacturing capabilities.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement